• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·India·Healthcare·SHALBY.NS
Share

Shalby Limited Stocks

₹ 164.52Last Updated 11.06.2026

Issuer Rating

4/7
Performance

Favourable

Risk

Considerable

Recommendation

Hold

Market Cap

₹ 190.32M

₹ 164.52
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very favourable analyst view

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Shalby Limited is a prominent healthcare organization primarily managing a network of multi-specialty hospitals across India. The company delivers an extensive spectrum of medical services, including advanced orthopedic care such as hip and knee joint replacements, arthroscopy, and arthroplasty, alongside comprehensive cardiology and cardiothoracic and vascular surgery. Its diverse offerings also encompass cosmetic and aesthetic procedures, dental implantology, emergency medicine, endocrinology, various forms of endoscopy and laparoscopy, ENT surgery, gastroentero surgery, gastroenterology, and general medical and surgical treatments. Further specialized services provided by Shalby include hair transplantation, liver disease and transplant management, infectious disease treatment, infertility and IVF solutions, intensive and critical care, maxillofacial surgery, nephrology, neurosurgery, neurology, obesity surgery, obstetrics and gynecology, oncology and oncosurgery, ophthalmology and glaucoma, pediatric orthopedics, pathology and microbiology, pediatrics and neonatology, plastic surgery, pulmonology and chest medicine, radiology and imaging, rheumatology, trauma care, organ donation, and urosurgery. The company operates 11 hospitals with a combined bed capacity of 2,012 and extends its reach through 50 outpatient clinics. Beyond direct patient care, Shalby is involved in medical education, offering programs and fellowships for paramedical students and other healthcare professionals. It also provides home-based healthcare services, covering attendants, doctors, nursing, physiotherapy, pathology, pharmacy, and medical equipment, and conducts clinical research trials. While its primary operations are in India, Shalby Limited also maintains an international presence in countries such such as Kenya, Tanzania, Rwanda, Uganda, the United Arab Emirates, Bangladesh, Cambodia, Jakarta, Oman, Uzbekistan, and Nepal. Established in 1994, the company was initially known as Shalby Hospitals Limited before adopting its current name in February 2008, and its headquarters are located in Ahmedabad, India.

Company Valuation

Fairly valued
4/7

From both historical and forecast perspectives, the stock is fairly priced compared to similar stocks. Specifically, the stock is 'expensive' on P/E, neutral on EV/EBITD.

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Very favourable
7/7

The average target price of SHALBY.NS is 310 and suggests 87% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to in

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

12.06.2026 01:34

Rally ahead of SpaceX debut: best day since April for S&P 500 and Nasdaq, oil down 5%

12.06.2026 01:01

SpaceX holds record IPO: Elon Musk's space company raises $75 billion

12.06.2026 00:55

Google discusses producing part of its new AI chip at Samsung factories. Is this a threat to TSMC?

12.06.2026 00:10

BofA raised its rating on Intel stock by two notches at once. What is the bank betting on?

11.06.2026 22:46

Trump canceled planned new strikes on Iran. Oil below $90 per barrel

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn
  • X (Twitter)
  • LinkedIn
Oninvest© 2026